Meeting of the Presidential Advisory Council on HIV/AIDS, 4671 [2020-01336]

Download as PDF Federal Register / Vol. 85, No. 17 / Monday, January 27, 2020 / Notices Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993–0002, 240– 402–7911; or Ei Thu Lwin, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 6236, Silver Spring, MD 20993–0002, 301– 796–0728. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of December 20, 2019 (84 FR 70196), FDA published a notice with a 60-day comment period to request comments on the draft guidance for industry entitled ‘‘Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products.’’ The Agency has received requests for extension of the comment period. The requests conveyed that additional time is needed to provide comments. FDA has considered the requests and is extending the comment period for 30 days, until March 19, 2020. The Agency believes that an additional 30 days will allow adequate time for interested persons to submit comments without compromising the timely publication of the final version of the guidance. II. Electronic Access Persons with access to the internet may obtain the draft guidance at either https://www.fda.gov/drugs/guidancecompliance-regulatory-information/ guidances-drugs, https://www.fda.gov/ vaccines-blood-biologics/guidancecompliance-regulatory-informationbiologics/biologics-guidances, or https:// www.regulations.gov. Dated: January 22, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–01322 Filed 1–24–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Presidential Advisory Council on HIV/AIDS Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. khammond on DSKJM1Z7X2PROD with NOTICES AGENCY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Service is hereby giving notice that the Presidential Advisory Council on HIV/ AIDS (PACHA or the Council) will be holding the 66th full Council meeting in SUMMARY: VerDate Sep<11>2014 16:54 Jan 24, 2020 Jkt 250001 Washington, DC. Agenda items will include: Discussion of Ending the HIV Epidemic: A Plan for America (EHE) Jurisdictional Plans, Focusing on the Four Pilot Sites: DeKalb County, Georgia; Baltimore, Maryland; East Baton Rouge, Louisiana; and the Cherokee Nation of Oklahoma; the Ready, Set, PrEP National Program; Stigma as a Barrier—Shared Experiences and Challenges from International and Domestic Perspectives; and Women and HIV. The meeting will be open to the public; a public comment session will be held during the meeting. Preregistration is encouraged for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or send in their public comment via email should send an email to PACHA@ hhs.gov. Pre-Registration must be complete by Monday, February 3, 2020. DATES: The Council meeting is scheduled to convene on Monday, February 10, 2020 from approximately 1:00 p.m. to 7:00 p.m. ET and Tuesday, February 11, 2020 from approximately 9:00 a.m. to 5:00 p.m. ET (times are tentative and subject to change). The meeting agenda will be posted on the PACHA web page at https:// www.hiv.gov/federal-response/pacha/ about-pacha. Public attendance is limited to available space. ADDRESSES: Grand Hyatt Washington, 1000 H Street NW, Washington, DC 20001. FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, MPA, Public Health Analyst, Presidential Advisory Council on HIV/AIDS, 330 C Street SW, Room L609A, Washington, DC 20024; (202) 795–7622 or PACHA@hhs.gov. Additional information can be obtained by accessing the Council’s page on the HIV.gov site at www.hiv.gov/pacha. SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 12963, dated June 14, 1995, as amended by Executive Order 13009, dated June 14, 1996 and is currently operating under the authority given in Executive Order 13889, dated September 27, 2019. The Council was established to provide advice, information, and recommendations to the Secretary regarding programs and policies intended to promote effective prevention and care of HIV infection and AIDS. The functions of the Council are solely advisory in nature. The Council consists of not more than 25 members. Council members are selected from prominent community leaders with particular expertise in, or knowledge of, matters concerning HIV PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 4671 and AIDS, public health, global health, philanthropy, marketing or business, as well as other national leaders held in high esteem from other sectors of society. Council members are appointed by the Secretary or designee, in consultation with the White House. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Caroline Talev at PACHA@hhs.gov. Due to space constraints, pre-registration for public attendance is advisable and can be accomplished by contacting PACHA@ hhs.gov by close of business Monday, February 3, 2020. Members of the public will have the opportunity to provide comments during the meeting. Comments will be limited to no more than three minutes per speaker. Any individual who wishes to participate in the public comment session must register with Caroline Talev at PACHA@ hhs.gov by close of business Monday, February 3, 2020; registration for public comment will not be accepted by telephone. Individuals are encouraged to provide a written statement of any public comment(s) for accurate minute taking purposes. Any members of the public who wish to have printed material distributed to PACHA members at the meeting are asked to submit, at a minimum, 1 copy of the material(s) to Caroline Talev, no later than close of business Monday, February 3, 2020. Dated: January 15, 2020. B. Kaye Hayes, Principal Deputy Director, Office of Infectious Disease and HIV/AIDS Policy, Executive Director, Presidential Advisory Council on HIV/AIDS, Office of the Assistant Secretary for Health, Department of Health and Human Services. [FR Doc. 2020–01336 Filed 1–24–20; 8:45 am] BILLING CODE 4150–43–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and E:\FR\FM\27JAN1.SGM 27JAN1

Agencies

[Federal Register Volume 85, Number 17 (Monday, January 27, 2020)]
[Notices]
[Page 4671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01336]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on HIV/AIDS

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Service is hereby giving notice that the 
Presidential Advisory Council on HIV/AIDS (PACHA or the Council) will 
be holding the 66th full Council meeting in Washington, DC. Agenda 
items will include: Discussion of Ending the HIV Epidemic: A Plan for 
America (EHE) Jurisdictional Plans, Focusing on the Four Pilot Sites: 
DeKalb County, Georgia; Baltimore, Maryland; East Baton Rouge, 
Louisiana; and the Cherokee Nation of Oklahoma; the Ready, Set, PrEP 
National Program; Stigma as a Barrier--Shared Experiences and 
Challenges from International and Domestic Perspectives; and Women and 
HIV. The meeting will be open to the public; a public comment session 
will be held during the meeting. Pre-registration is encouraged for 
members of the public who wish to attend the meeting and who wish to 
participate in the public comment session. Individuals who wish to 
attend the meeting and/or send in their public comment via email should 
send an email to [email protected]. Pre-Registration must be complete by 
Monday, February 3, 2020.

DATES: The Council meeting is scheduled to convene on Monday, February 
10, 2020 from approximately 1:00 p.m. to 7:00 p.m. ET and Tuesday, 
February 11, 2020 from approximately 9:00 a.m. to 5:00 p.m. ET (times 
are tentative and subject to change). The meeting agenda will be posted 
on the PACHA web page at https://www.hiv.gov/federal-response/pacha/about-pacha. Public attendance is limited to available space.

ADDRESSES: Grand Hyatt Washington, 1000 H Street NW, Washington, DC 
20001.

FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, MPA, Public Health 
Analyst, Presidential Advisory Council on HIV/AIDS, 330 C Street SW, 
Room L609A, Washington, DC 20024; (202) 795-7622 or [email protected]. 
Additional information can be obtained by accessing the Council's page 
on the HIV.gov site at www.hiv.gov/pacha.

SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 
12963, dated June 14, 1995, as amended by Executive Order 13009, dated 
June 14, 1996 and is currently operating under the authority given in 
Executive Order 13889, dated September 27, 2019. The Council was 
established to provide advice, information, and recommendations to the 
Secretary regarding programs and policies intended to promote effective 
prevention and care of HIV infection and AIDS. The functions of the 
Council are solely advisory in nature.
    The Council consists of not more than 25 members. Council members 
are selected from prominent community leaders with particular expertise 
in, or knowledge of, matters concerning HIV and AIDS, public health, 
global health, philanthropy, marketing or business, as well as other 
national leaders held in high esteem from other sectors of society. 
Council members are appointed by the Secretary or designee, in 
consultation with the White House.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify Caroline Talev at [email protected]. Due to space constraints, pre-
registration for public attendance is advisable and can be accomplished 
by contacting [email protected] by close of business Monday, February 3, 
2020. Members of the public will have the opportunity to provide 
comments during the meeting. Comments will be limited to no more than 
three minutes per speaker. Any individual who wishes to participate in 
the public comment session must register with Caroline Talev at 
[email protected] by close of business Monday, February 3, 2020; 
registration for public comment will not be accepted by telephone. 
Individuals are encouraged to provide a written statement of any public 
comment(s) for accurate minute taking purposes. Any members of the 
public who wish to have printed material distributed to PACHA members 
at the meeting are asked to submit, at a minimum, 1 copy of the 
material(s) to Caroline Talev, no later than close of business Monday, 
February 3, 2020.

    Dated: January 15, 2020.
B. Kaye Hayes,
Principal Deputy Director, Office of Infectious Disease and HIV/AIDS 
Policy, Executive Director, Presidential Advisory Council on HIV/AIDS, 
Office of the Assistant Secretary for Health, Department of Health and 
Human Services.
[FR Doc. 2020-01336 Filed 1-24-20; 8:45 am]
BILLING CODE 4150-43-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.